Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

NCT00401219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Estrogen Replacement Therapy

Interventions

DRUG: conjugated estrogens/progestin (MPA)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer